PTK2 and neoplasm: If it were possible to establish this type of inhibitor in therapy, there would also be potent means available to have a negative effect on the tumor-promoting microenvironment via the nuclear function of FAK, since nuclear FAK, as already discussed, stimulates the expression of the VEGFR.